Results 1 to 10 of about 313,983 (338)

RNAi efficiency, systemic properties, and novel delivery methods for pest insect control : what we know so far [PDF]

open access: yesFrontiers in Physiology, 2016
In recent years, the research on the potential of using RNA interference (RNAi) to suppress crop pests has made an outstanding growth. However, given the variability of RNAi efficiency that is observed in many insects, the development of novel approaches
Christiaens, Olivier   +3 more
core   +3 more sources

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by hepatic overproduction of oxalate that leads to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. Lumasiran, an investigational RNA interference (RNAi)
Sander F. Garrelfs   +24 more
semanticscholar   +1 more source

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

open access: yesJournal of Pharmacology and Experimental Therapeutics, 2022
RNA interference (RNAi) provides researchers with a versatile means to modulate target gene expression. The major forms of RNAi molecules, genome-derived microRNAs (miRNAs) and exogenous small interfering RNAs (siRNAs), converge into RNA-induced ...
G. Traber, A. Yu
semanticscholar   +1 more source

Off-target effects of RNAi correlate with the mismatch rate between dsRNA and non-target mRNA

open access: yesRNA Biology, 2021
RNAi is a potent technique for the knockdown of target genes. However, its potential off-target effects limit the widespread applications in both reverse genetic analysis and genetic manipulation.
Jiasheng Chen   +7 more
semanticscholar   +1 more source

Insight Into the Prospects for RNAi Therapy of Cancer

open access: yesFrontiers in Pharmacology, 2021
RNA interference (RNAi), also known as gene silencing, is a biological process that prevents gene expression in certain diseases such as cancer. It can be used to improve the accuracy, efficiency, and stability of treatments, particularly genetic ...
Zhili Tian   +7 more
semanticscholar   +1 more source

Antiviral RNA Interference against Orsay Virus Is neither Systemic nor Transgenerational in Caenorhabditis elegans. [PDF]

open access: yes, 2015
UNLABELLED: Antiviral RNA-mediated silencing (RNA interference [RNAi]) acts as a powerful innate immunity defense in plants, invertebrates, and mammals. In Caenorhabditis elegans, RNAi is systemic; i.e., RNAi silencing signals can move between cells and ...
Ashe, Alyson   +4 more
core   +5 more sources

Modeling recursive RNA interference. [PDF]

open access: yes, 2008
An important application of the RNA interference (RNAi) pathway is its use as a small RNA-based regulatory system commonly exploited to suppress expression of target genes to test their function in vivo.
A Dillin   +52 more
core   +5 more sources

A Perspective on RNAi-Based Biopesticides

open access: yesFrontiers in Plant Science, 2020
Sustainable agriculture relies on practices and technologies that combine effectiveness with a minimal environmental footprint. RNA interference (RNAi), a eukaryotic process in which transcript expression is reduced in a sequence-specific manner, can be ...
Stephen J. Fletcher   +3 more
semanticscholar   +1 more source

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Patisiran, an investigational RNA interference therapeutic agent, specifically inhibits hepatic synthesis of transthyretin. METHODS In this phase 3 trial, we randomly assigned patients with hereditary transthyretin amyloidosis with ...
D. Adams   +35 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy